MedTrace Logo

Infant RSV Infections and Health-related Quality of Life of Families

NCT05550545 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2022-10-18

No results posted yet for this study

Summary

Until today, there is only little information available on how severe RSV infection leading to hospitalisation of the infant impacts the quality of life of affected families. For the ResQ Family project, an online questionnaire will be used to survey parents or caregivers of children up to 24 months currently or recently hospitalised (length of hospital stay of at least 12 hours and hospital admission no longer than 4 weeks ago) due to RSV infection.

The aim of the ResQ Family project is to find out how infant RSV hospitalisation impacts the quality of life of affected children and their families. The goal is further to provide scientific evidence on the burden of RSV and raise awareness among all relevant stakeholders including healthcare professionals and patient representatives, decision-makers and the general public. The project will run until June 2024. Data collection will take place during the RSV season from fall 2022 to spring 2023 in four European countries: France, Germany, Italy, and Sweden.

Conditions

  • RSV Infection
  • Quality of Life
  • Infant ALL
  • Caregiver Burden
  • Family

Interventions

OTHER

cohort study

Please note that this is an observational study; not applicable

Sponsors & Collaborators

  • Respiratory Syncytial Virus Foundation (ReSViNET)

    collaborator UNKNOWN

  • European Society for Paediatric Research (ESPR)

    collaborator UNKNOWN

  • Union of European Neonatal and Perinatal Societies (UENPS)

    collaborator UNKNOWN

  • Global Foundation for the Care of Newborn Infants

    lead OTHER

Principal Investigators

  • Johanna Kostenzer, PhD · Global Foundation for the Care of Newborn Infants

Eligibility

Min Age
0 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-29
Primary Completion
2023-05-31
Completion
2024-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05550545 on ClinicalTrials.gov